- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03620383
Radial Artery Vasodilation Heat Study
August 27, 2019 updated by: Ramsey Al-Hakim, Oregon Health and Science University
Radial Artery Vasodilation With Distal Topical Heat Study
The purpose of this study is to collect data about the efficacy of utilizing distal topical heat application for dilatation of the radial artery.
Transradial arterial access is widely accepted as the standard of care for cardiac catheterization procedures due to its increased patient comfort and significantly decreased risk of major vascular complications, and has been recently utilized in increasing volume by the interventional radiology community throughout the world.
Due to the small size of the radial artery, catheterization may sometimes be technically difficult.
Pre-procedure dilatation can make catheterization significantly easier, and studies have demonstrated the successful ability to dilate the radial artery with the use of topical nitroglycerin and lidocaine.
However, the investigators hypothesize that utilizing topical heat applied distally can create a physiologic vasodilatation similar to that created with nitroglycerin and lidocaine, but at a significantly lower cost and with less risk due to no need for application of a medication which has a systemic effect with known side effects.
The purpose of this study is to test the efficacy of radial artery vasodilatation with distal topical heat application.
Study Overview
Detailed Description
The study will be designed to detect a significant increase in the radial artery diameter of healthy volunteers after the application of a warm heat pack in the palmar aspect of the hand compared to a control group without heat applied to the hand.
Employees and students at OHSU will be considered for enrollment as volunteers for this minimal risk study.
Informed consent will be obtained from healthy volunteers prior to enrollment.
After enrollment, the healthy volunteers will be randomly assigned in a 2:1 ratio to the heat group (Group 1) or the control group (Group 2), respectively.
A brief medical history will be obtained from all volunteers, including age, sex, medications, prior interventions, prior surgeries, previous medical diagnoses, allergies, and any history of prior transradial procedures.
For protection of confidential health information, brief medical history will be obtained in a private area.
The volunteers will then be seated and the left hand placed supinated in a comfortable position on a table.
A limited ultrasound of the left radial artery will be performed using grayscale ultrasound.
A skin mark will be made with a marker to identify the measurement site.
All volunteers will then be given a commercially available warm heat pack and asked to hold gently in their left hand.
For the control group (Group 2), the warm heat pack will not be activated.
For the heat group (Group 1), the warm heat back will be activated prior to placing in the volunteer's hand.
Two investigators will be present.
One investigator will be measuring radial artery diameter and will not be aware if the heat pack is activated.
The second investigator will be aware of the volunteer's randomly assigned group and will activate the heat pack for the volunteer if they are assigned to Group 1.
Over a period of 20 minutes, repeat ultrasound of the left radial artery will be performed in 5 minute intervals.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Volunteers who are 18-99 years old
Exclusion Criteria:
- Prior left transradial access for procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Heat
Distal topical heat application
|
Warm heat pack applied topically in participant hand.
|
|
NO_INTERVENTION: No Heat
Inactive heat pack to blind the investigator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radial Artery Cross Sectional Area
Time Frame: 20 minutes after application of topical heat
|
Radial artery cross sectional area after 20 minutes with or without heat application
|
20 minutes after application of topical heat
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ramsey Al-Hakim, MD, Oregon Health and Science University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 3, 2018
Primary Completion (ACTUAL)
September 17, 2018
Study Completion (ACTUAL)
September 18, 2018
Study Registration Dates
First Submitted
August 3, 2018
First Submitted That Met QC Criteria
August 7, 2018
First Posted (ACTUAL)
August 8, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 25, 2019
Last Update Submitted That Met QC Criteria
August 27, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00018794
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.